Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 5, 2010, Pages 374-380

  Chong, Eric ^a,b,c   Poh, Kian K ^b,c   Liang, Shen ^c   Tan, Huay C ^b,c  

^a National University Hospital

^b National University Hospital

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anaemia; Female gender; Haemoglobin; Left ventricular ejection fraction

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; CREATININE; INSULIN; IOHEXOL; CONTRAST MEDIUM;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIET THERAPY; FEMALE; GENDER; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; RISK FACTOR; TREATMENT OUTCOME; BLOOD; CHEMICALLY INDUCED; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FUNCTION; KIDNEY DISEASE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; SEX DIFFERENCE; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; CREATININE; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPOTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77953412315     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Rihal CS. Textor SC. Grill DE. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64.
2. Best PJ. Lennon R. Ting HH. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous interventions. J Am Coll Cardiol 2002;39:1113-9.
3. McCullough PA. Wolyn R. Rocher LL. Levin RN. O'Neill WW. Acute renal failure after coronary intervention: incidence. risk factors and relationship to mortality. Am J Med 1997;103:368-75.
4. McCullough PA. Soman SS. Shah SS. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000;36:679-84.
5. Parfrey PS. Griffiths SM. Barrett BJ. Contrast material-induced renal failure in patients with diabetes mellitus. renal insufficiency. or both. N Engl J Med 1989;320:143-9.
6. Gruberg L. Mintz GS. Mehran R. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-8.
7. Mehran R. Aymong ED. Nikolsky E. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9.
8. Briguori C. Manganelli F. Scarpato P. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002;40:298-303.
9. Solomon R. Werner C. Mann D. D'Ella J. Silva P. Effects of saline. mannitol. and furosemide on acute changes in renal function induced by radiocontrast agents. N Engl J Med 1994;331:403-11.
10. Pannu N. Wiebe N. Tonelli M. Alberta Kidney Disease Network. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765-79.
11. Cigarroa RG. Lange RA. Williams RH. Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649-52.
12. Iakovou I, Dangas G, Mehran R. Impact of gender on the incidence and outcome of contrast-Induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003;15:18-22.
13. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002;137:555-62.
14. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990;150:1237-42.
15. Wright RS, Reeder GS, Herzog CA. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002;137:563-70.
16. Walsh CR, O'Donnell CJ, Camargo CA, Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 2002;144:1003-11.
17. Merten GJ, Burgess WP, Gray LV. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-34.
18. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteineto prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002;89:356-8.
19. Aspelin P, Aubry P, Fransson SG. Nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-9.
20. Schwab SJ, Hlatky MA, Pieper KS. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989;320:149-53.
21. Van de Werf F, Ardissino D, Betriu A. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003;24:28-66.
22. ACC/AHAGuidelines for the Management ofPatients With ST-Elevation Myocardial Infarction-Executive Summary A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004;110:588-636.
23. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. Circulation 2006;113:156-75.
24. Rihal CS, Textor SC, Grill DE. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64.
25. Hollenberg SM, Kavinsky C, Parrillo JE. Review - cardiogenic shock. Ann Intern Med 1999;131:47-59.
26. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-6.
27. Sadeghi HM, Stone GW, Grines CL. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003;108:2769-75.
28. Rubenstein MH, Sheynberg BV, Harrell LC, Schunkert H, Bazari H, Palacios IF. Effectiveness and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 2001;87:856-60.
29. Nikolsky E, Mehran R, Turcot D. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004;94:300-5.
30. Marenzi G, Lauri G, Guazzi M. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis. Am J Med Sci 2001;321:359-66.
31. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281:2005-12.
32. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
33. Wison S, Foo K, Cunningham J. Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 2003;91:1051-4.
34. Hannan EL, Racz MJ, Arani DT, Ryan TJ, Walford G, McCallister BD. Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000;36:1194-201.
35. Massicotte A. Contrast medium-induced nephropathy: strategies for prevention. Pharmacotherapy 2008;28:1140-50.
36. Marenzi G, BartorelliAL, Lauri G. Continuous veno-venoushemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions. Cathet Cardiovasc Intervent 2003;58:59-64.
37. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805.